FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033991662> ?p ?o ?g. }

• W3033991662 endingPage "141" @default.
• W3033991662 startingPage "129" @default.
• W3033991662 abstract "Various therapeutic approaches, for example, in case of trauma or cancer require the transplantation of autologous tissue. Depending on the size and the origin of the harvested tissue, these therapies can lead to iatrogenic complications and donor-site morbidities. In future, these side effects could be avoided by transplanting artificially generated tissue consisting of different cell types and matrix components derived from the host body. Tissue that is grown in the patient could be advantageous compared with the more simply structured in vitro-grown alternatives. To overcome the limitations of graft vascularization, the arteriovenous (AV) loop technique has been established for different tissues in the last years and was adapted for lymphatic tissue engineering in the present study. We utilized the AV loop technique to grow human lymphatic vasculature in vivo in the Rowett nude (RNU) rat. A combination of human lymphatic endothelial cells (LECs) and bone marrow-derived mesenchymal stem cells was implanted in a fibrin matrix surrounding the AV loop. After 2 or 4 weeks of implantation, the animals were perfused and the tissue was harvested. It could be demonstrated by immunohistochemistry for human LYVE1, human CD31, and murine podoplanin that the implanted cells formed human lymphatic vasculature in the AV loop chamber. Beside development of murine podoplanin-positive vasculature in the AV loop tissue, vasculature positive for human marker proteins developed in comparable numbers. This suggests that implanted LECs are able to improve the lymphatic vascularization of the newly engineered tissue. Thus, we were able to establish an in vivo tissue engineering method to generate lymphatic vascularized soft tissue. An axially vascularized transplantable lymphatic vessel network was engineered without requiring advanced cell culture equipment, rendering the lymphatic AV loop highly suitable for applied regenerative medicine. Various surgical procedures require the transplantation of autologous harvested tissue, for example, the vascularized lymph node transfer for the treatment of lymphedema. Tissue-engineered transplants could be used instead of autologous transplants and thereby help to reduce the side effects of those therapies. However, in vitro tissue engineering of large constructs requires a lot of know-how as well as advanced cell culture equipment, which might not be accessible in every hospital. In vivo tissue engineering approaches like the presented technique for the generation of transplantable networks of lymphatic vasculature could serve as an alternative for in vitro tissue engineering approaches in clinical settings." @default.
• W3033991662 created "2020-06-12" @default.
• W3033991662 creator A5006429344 @default.
• W3033991662 creator A5062111817 @default.
• W3033991662 creator A5066577132 @default.
• W3033991662 creator A5069245069 @default.
• W3033991662 creator A5071979310 @default.
• W3033991662 creator A5077430076 @default.
• W3033991662 creator A5077775036 @default.
• W3033991662 creator A5085427773 @default.
• W3033991662 date "2021-01-01" @default.
• W3033991662 modified "2023-09-27" @default.
• W3033991662 title "Tissue Engineering of Lymphatic Vasculature in the Arteriovenous Loop Model of the Rat" @default.
• W3033991662 cites W1965371866 @default.
• W3033991662 cites W1976604464 @default.
• W3033991662 cites W2004822806 @default.
• W3033991662 cites W2025371271 @default.
• W3033991662 cites W2030426885 @default.
• W3033991662 cites W2035356610 @default.
• W3033991662 cites W2036296187 @default.
• W3033991662 cites W2036839600 @default.
• W3033991662 cites W2040548997 @default.
• W3033991662 cites W2045663895 @default.
• W3033991662 cites W2060372448 @default.
• W3033991662 cites W2065317648 @default.
• W3033991662 cites W2099126984 @default.
• W3033991662 cites W2099366913 @default.
• W3033991662 cites W2107503723 @default.
• W3033991662 cites W2113265524 @default.
• W3033991662 cites W2121162934 @default.
• W3033991662 cites W2125728570 @default.
• W3033991662 cites W2130516299 @default.
• W3033991662 cites W2132992599 @default.
• W3033991662 cites W2140119911 @default.
• W3033991662 cites W2150305156 @default.
• W3033991662 cites W2159404520 @default.
• W3033991662 cites W2177723774 @default.
• W3033991662 cites W2299898281 @default.
• W3033991662 cites W2317982666 @default.
• W3033991662 cites W2606107018 @default.
• W3033991662 cites W2608476429 @default.
• W3033991662 cites W2767390940 @default.
• W3033991662 cites W2791369334 @default.
• W3033991662 cites W2800264469 @default.
• W3033991662 cites W2808830376 @default.
• W3033991662 cites W2890155038 @default.
• W3033991662 cites W2903576457 @default.
• W3033991662 cites W2910636719 @default.
• W3033991662 cites W2921134457 @default.
• W3033991662 cites W2944267995 @default.
• W3033991662 cites W2954960125 @default.
• W3033991662 cites W2999132126 @default.
• W3033991662 cites W4232266176 @default.
• W3033991662 doi "https://doi.org/10.1089/ten.tea.2020.0108" @default.
• W3033991662 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32524901" @default.
• W3033991662 hasPublicationYear "2021" @default.
• W3033991662 type Work @default.
• W3033991662 sameAs 3033991662 @default.
• W3033991662 citedByCount "11" @default.
• W3033991662 countsByYear W30339916622021 @default.
• W3033991662 countsByYear W30339916622022 @default.
• W3033991662 countsByYear W30339916622023 @default.
• W3033991662 crossrefType "journal-article" @default.
• W3033991662 hasAuthorship W3033991662A5006429344 @default.
• W3033991662 hasAuthorship W3033991662A5062111817 @default.
• W3033991662 hasAuthorship W3033991662A5066577132 @default.
• W3033991662 hasAuthorship W3033991662A5069245069 @default.
• W3033991662 hasAuthorship W3033991662A5071979310 @default.
• W3033991662 hasAuthorship W3033991662A5077430076 @default.
• W3033991662 hasAuthorship W3033991662A5077775036 @default.
• W3033991662 hasAuthorship W3033991662A5085427773 @default.
• W3033991662 hasConcept C10854531 @default.
• W3033991662 hasConcept C136229726 @default.
• W3033991662 hasConcept C141071460 @default.
• W3033991662 hasConcept C142724271 @default.
• W3033991662 hasConcept C150903083 @default.
• W3033991662 hasConcept C181152851 @default.
• W3033991662 hasConcept C189165786 @default.
• W3033991662 hasConcept C198826908 @default.
• W3033991662 hasConcept C204232928 @default.
• W3033991662 hasConcept C207001950 @default.
• W3033991662 hasConcept C2778939058 @default.
• W3033991662 hasConcept C28328180 @default.
• W3033991662 hasConcept C2910366181 @default.
• W3033991662 hasConcept C2911091166 @default.
• W3033991662 hasConcept C49892992 @default.
• W3033991662 hasConcept C71924100 @default.
• W3033991662 hasConcept C86803240 @default.
• W3033991662 hasConcept C95444343 @default.
• W3033991662 hasConceptScore W3033991662C10854531 @default.
• W3033991662 hasConceptScore W3033991662C136229726 @default.
• W3033991662 hasConceptScore W3033991662C141071460 @default.
• W3033991662 hasConceptScore W3033991662C142724271 @default.
• W3033991662 hasConceptScore W3033991662C150903083 @default.
• W3033991662 hasConceptScore W3033991662C181152851 @default.
• W3033991662 hasConceptScore W3033991662C189165786 @default.
• W3033991662 hasConceptScore W3033991662C198826908 @default.
• W3033991662 hasConceptScore W3033991662C204232928 @default.

• next